Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P13945: Variant p.Arg353Cys

Beta-3 adrenergic receptor
Gene: ADRB3
Feedback?
Variant information Variant position: help 353 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Cysteine (C) at position 353 (R353C, p.Arg353Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help The variant Arg-64 seems to be associated with weight gain (obesity) and is also associated with susceptibility to non-insulin-dependent diabetes mellitus (NIDDM). Additional information on the polymorphism described.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 353 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 408 The length of the canonical sequence.
Location on the sequence: help WLGYANSAFNPLIYCRSPDF R SAFRRLLCRCGRRLPPEPCA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         WLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCA

                              WLGYANSAFNPLIYCRSPDFRSAFRRLLCRCR---REEHRA

Rhesus macaque                WLGYANSAFNPLIYCRSPDFRSAFRRLLCHCGGRLPREPCA

Mouse                         WLGYANSAFNPVIYCRSPDFRDAFRRLLCSYGGRGPEEPRA

Rat                           WLGYANSAFNPLIYCRSPDFRDAFRRLLCSYGGRGPEEPRV

Pig                           WLGYANSAFNPLIYCHSPDFRSAFRRLLCRCG---PEEHLA

Bovine                        WLGYANSAFNPLIYCRSPDFRSAFRRLLCRCR---PEEHLA

Goat                          WLGYANSAFNPLIYCRSPDFQSAFRRLLCRCR---PEEHLA

Sheep                         WLGYANSAFNPLIYCRSPDFRSAFRRLLCRCP---PEEHLA

Cat                           WLGYANSAFNPLIYCRSPDFRSAFRRLLCRCR---LEERHA

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 408 Beta-3 adrenergic receptor
Topological domain 348 – 408 Cytoplasmic
Lipidation 361 – 361 S-palmitoyl cysteine



Literature citations
Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS ARG-64 AND CYS-353;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.